Abstract: A juicer including: a driving part composed of a housing having a housing hollow part formed therein, and having a through-hole through which inner air is discharged at the position eccentric to one side in the width direction from the central portion formed on the bottom portion thereof, and a motor provided the housing hollow part by being surrounded by a motor housing; a juice part connected to the driving part to be driven to squeeze the juice; and a fastening part for detachably coupling the juice part to the driving part.

Abstract: Disclosed is a system for controlling a power-up sequence applicable to a power controller of a lane departure warning system, including: one DC/DC converter unit configured to convert a first input voltage of input power and output the converted first input voltage as a first output voltage, and including four output terminals; and a comparator block unit including two comparators configured to monitor a state of the input power, and one or more comparators configured to generate a control signal for enabling a power output of a next sequence from the first output voltage.

Abstract: Disclosed is a system for controlling a power-up sequence applicable to a power controller of a lane departure warning system, including: one DC/DC converter unit configured to convert a first input voltage of input power and output the converted first input voltage as a first output voltage, and including four output terminals; and a comparator block unit including two comparators configured to monitor a state of the input power, and one or more comparators configured to generate a control signal for enabling a power output of a next sequence from the first output voltage.

Abstract: Disclosed is a method for preparing activated lymphocytes, which comprises isolating lymphocytes from peripheral blood and proliferating and activating the isolated lymphocytes in vitro. According to the disclosed method, highly effective toxic cells can be prepared in large amounts by culturing human peripheral lymphocytes in the presence of an anti-CD3 antibody, IFN-? and IL-2. The activated lymphocytes proliferated according to the disclosed preparation method comprise both CD3-CD56+ (natural killer cell marker) cells that are the main components of LAK cells, and CD3+CD56+ cells that are the main components of CIK cells, and can be cultured in large amounts. Thus, the lymphocyte cells can show a significantly higher anticancer effect compared to when the LAK cells and the CIK cells are used alone.